First Niagara Bank’s GSK GSK Stock Holding History

First Niagara Bank’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	$337K	Hold	6,222	–	–	0.1%	141
2016 Q1	$315K	Hold	6,222	–	–	0.09%	147
2015 Q4	$314K	Sell	6,222 -3,200	-34%	-$163K	0.09%	150
2015 Q3	$453K	Sell	9,422 -60	-0.6%	-$3.12K	0.12%	141
2015 Q2	$494K	Sell	9,482 -1,040	-10%	-$58.6K	0.11%	137
2015 Q1	$607K	Sell	10,522 -10	-0.1%	-$573	0.13%	123
2014 Q4	$563K	Sell	10,532 -196	-2%	-$11K	0.12%	128
2014 Q3	$617K	Buy	10,728 +392	+4%	+$24K	0.13%	127
2014 Q2	$691K	Sell	10,336 -405	-4%	-$27.4K	0.14%	124
2014 Q1	$718K	Sell	10,741 -1,600	-13%	-$108K	0.14%	128
2013 Q4	$823K	Hold	12,341	–	–	0.16%	124
2013 Q3	$438K	Sell	12,341 -560	-4%	-$36K	0.09%	158
2013 Q2	$806K	Buy	+12,901	New	+$819K	0.17%	118

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

First Niagara Bank's GSK Position: Q2 2016 in Review

First Niagara Bank held its GSK (GSK) position steady in Q2 2016 at 6,222 shares worth $337K. The position accounts for 0.1% of the portfolio, ranked #141.

First Niagara Bank first reported a position in GSK in Q2 2013 and has held it in 13 quarters since. The position peaked at $823K in Q4 2013. 742 funds tracked by Wall St. Rank hold GSK as of Q2 2016.

First Niagara Bank held 6,222 shares of GSK worth $337K as of Q2 2016.
First Niagara Bank left its GSK share count unchanged in Q2 2016.
GSK made up 0.1% of First Niagara Bank's portfolio in Q2 2016, its #141 holding.
First Niagara Bank first reported a position in GSK in Q2 2013 and has held it in 13 quarters since.
First Niagara Bank's GSK position peaked at $823K in Q4 2013.
742 funds tracked by Wall St. Rank held GSK as of Q2 2016.

Based on First Niagara Bank's 13F filing for Q2 2016, filed 25 Jul 2016.